Total Nilai Perusahaan: Evoke Pharma, Inc. (EVOK)

Evoke Pharma, Inc. (EVOK) acts as a biopharmaceutical pioneer that has implemented an original nasal drug delivery method. The company created Gimoti, the only spray for the therapy of gastroparesis that remains effective even during a complete gastrointestinal blockage. Currently, the business is focused on the commercialization of this convenient alternative to tablets, and the available price action reflects an Enterprise Value of 12.45.
Evoke Pharma, Inc. (EVOK) - rincian metrik lan laporan keuangan

Enterprise value combines market capitalization with net debt, determining the actual cost of a full business buyout accounting for all liabilities and cash reserves. For Evoke Pharma, Inc. (EVOK), which optimizes nasal spray logistics to maintain high margins, the enterprise value on this chart reflects the fundamental resilience of assets and the extent of the premium paid for current distribution efficiency.